Serving leading biopharmaceutical companies globally:

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Laronidase - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for laronidase

Tradenames:	1
Patents:	20
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for laronidase

Recent Clinical Trials for laronidase

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Masonic Cancer Center, University of Minnesota	N/A
The Ryan Foundation	N/A
BioMarin Pharmaceutical	N/A

See all laronidase clinical trials

Pharmacology for laronidase

Ingredient-type	alpha-Glucosidases

Patent Text Search: US Patents for laronidase

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Biomarin	ALDURAZYME	laronidase	VIAL	125058	001	2003-04-30	Start Trial	AviGenics, Inc. (Athens, GA)	2021-11-30	RX		search
Biomarin	ALDURAZYME	laronidase	VIAL	125058	001	2003-04-30	Start Trial	AviGenics, Inc. (Athens, GA)	2021-11-30	RX		search
Biomarin	ALDURAZYME	laronidase	VIAL	125058	001	2003-04-30	Start Trial	Synageva BioPharma Corp. (Waltham, MA)	2021-11-30	RX		search
Biomarin	ALDURAZYME	laronidase	VIAL	125058	001	2003-04-30	Start Trial	Amunix Operating, Inc. (Mountain View, CA)	2025-09-27	RX		search
Biomarin	ALDURAZYME	laronidase	VIAL	125058	001	2003-04-30	Start Trial	The University of British Columbia (Vancouver, CA)	2039-03-29	RX		search
Biomarin	ALDURAZYME	laronidase	VIAL	125058	001	2003-04-30	Start Trial	CMC Biologics A/S (Soeborg, Copenhagen, DK)	2027-06-13	RX		search
Biomarin	ALDURAZYME	laronidase	VIAL	125058	001	2003-04-30	Start Trial	Momenta Pharmaceuticals, Inc. (Cambridge, MA)	2028-12-19	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for laronidase

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
European Patent Office	2863222	Start Trial
China	101583370	Start Trial
Denmark	2171034	Start Trial
Singapore	191836	Start Trial
Singapore	10201604810U	Start Trial
South Korea	20170120726	Start Trial
South Korea	20140146062	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Moodys

Medtronic

Dow

McKesson

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.